Safety, Immunogenicity of Investigational Inactivated Whole-Virus COVID-19 Vaccine
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.
An investigational inactivated whole-virus COVID-19 vaccine has demonstrated safety and immunogenicity, according to an interim analysis.
The rates of myocardial infarction were found to decline during the COVID-19 pandemic, which also saw increases in sleep duration.
Researchers sought to identify and characterize stroke in COVID-19 in a single healthcare system in New York.